NYSE:MET - Metlife Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$44.23 +0.03 (+0.07 %)
(As of 07/16/2018 10:06 AM ET)
Previous Close$44.19
Today's Range$44.14 - $44.41
52-Week Range$43.09 - $55.91
Volume34,723 shs
Average Volume6.05 million shs
Market Capitalization$44.93 billion
P/E Ratio9.83
Dividend Yield3.80%
Metlife logoMetLife, Inc. engages in the insurance, annuities, employee benefits, and asset management businesses. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short- and long-term disability, individual disability, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and stable value products, including general and separate account guaranteed interest contracts, and private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, tort settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. In addition, the company offers automobile, homeowners', and personal excess liability, as well as small business owners' property, liability, and business interruption insurance products. Further, it provides fixed annuities and pension products; medical and credit insurance products; variable, universal, term, endowment, and whole life insurance products; variable, and fixed and indexed-linked annuities; and protection against costs of long-term health care services. MetLife, Inc. has a strategic alliance with Ernst & Young LLP. The company serves individuals, corporations and their employees, and other institutions through independent agents, property and casualty specialists, sales forces, sales teams and relationship managers, and other organizations, as well as through career agency, bancassurance, direct marketing, brokerage, and other third-party distribution and e-commerce channels. MetLife, Inc. was founded in 1863 and is headquartered in New York, New York.

Receive MET News and Ratings via Email

Sign-up to receive the latest news and ratings for MET and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NYSE
Industry Life insurance
Sub-IndustryLife & Health Insurance


Debt-to-Equity Ratio0.30
Current Ratio0.15
Quick Ratio0.15


Trailing P/E Ratio9.83
Forward P/E Ratio8.72
P/E Growth0.76

Sales & Book Value

Annual Sales$62.09 billion
Price / Sales0.72
Cash Flow$4.4813 per share
Price / Cash9.87
Book Value$55.94 per share
Price / Book0.79


EPS (Most Recent Fiscal Year)$4.50
Net Income$4.01 billion
Net Margins6.48%
Return on Equity8.70%
Return on Assets0.68%


Outstanding Shares1,016,530,000
Market Cap$44,930.67

The Truth About Cryptocurrencies

Metlife (NYSE:MET) Frequently Asked Questions

What is Metlife's stock symbol?

Metlife trades on the New York Stock Exchange (NYSE) under the ticker symbol "MET."

How often does Metlife pay dividends? What is the dividend yield for Metlife?

Metlife announced a quarterly dividend on Friday, July 6th. Investors of record on Monday, August 6th will be paid a dividend of $0.42 per share on Thursday, September 13th. This represents a $1.68 dividend on an annualized basis and a yield of 3.80%. The ex-dividend date of this dividend is Friday, August 3rd. View Metlife's Dividend History.

How will Metlife's stock buyback program work?

Metlife declared that its board has approved a share repurchase program on Tuesday, May 22nd 2018, which allows the company to repurchase $1,500,000,000.00 in shares, according to EventVestor. This repurchase authorization allows the company to repurchase up to 3.1% of its shares through open market purchases. Shares repurchase programs are often a sign that the company's management believes its stock is undervalued.

How were Metlife's earnings last quarter?

Metlife Inc (NYSE:MET) released its quarterly earnings data on Wednesday, May, 2nd. The financial services provider reported $1.36 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $1.17 by $0.19. The financial services provider earned $15.15 billion during the quarter, compared to analysts' expectations of $15.52 billion. Metlife had a return on equity of 8.70% and a net margin of 6.48%. The business's revenue for the quarter was up .6% on a year-over-year basis. During the same period in the prior year, the company earned $1.20 EPS. View Metlife's Earnings History.

What price target have analysts set for MET?

17 analysts have issued 1-year target prices for Metlife's stock. Their forecasts range from $47.00 to $78.00. On average, they anticipate Metlife's stock price to reach $57.0714 in the next twelve months. This suggests a possible upside of 29.1% from the stock's current price. View Analyst Ratings for Metlife.

What is the consensus analysts' recommendation for Metlife?

17 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Metlife in the last year. There are currently 9 hold ratings and 8 buy ratings for the stock, resulting in a consensus recommendation of "Hold."

What are Wall Street analysts saying about Metlife stock?

Here are some recent quotes from research analysts about Metlife stock:
  • 1. According to Zacks Investment Research, "MetLife’s shares have lost more than its industry’s decline in the past year. Moreover, the company has witnessed its 2019 estimates move downward over the last 30- days. The company’s exposure to catastrophe losses and investment in efficiency programs will put pressure on margins. However, its efforts to streamline business, only to focus on core business are really impressive. Its revenues grew in 2017 after declining for two years and the trend is likely to continue in 2018. Its strong international operations and disciplined capital management should drive long-term growth." (7/10/2018)
  • 2. Wells Fargo & Co analysts commented, "We hosted investor meetings with MetLife today (March 15) at the company’s NYC headquarters. From MET were Steven Kandarian, President, Chairman & CEO; John Hele, EVP & CFO; and John Hall, SVP & Head of IR. Investors were focused on MET’s material weaknesses (MW), unit cost initiative (UCI), long term care reserves, Brighthouse exchange offer, and reinsurance opportunities with MetLife Holdings. To us, the investment case for MET remains unchanged – faster growth in less capital intensive and less volatile businesses should lower the company’s cost of equity, which in turn should allow MetLife to achieve a higher ROE spread as well as a higher valuation multiple. We reiterate our Outperform rating on MET, which is also our top pick." (3/16/2018)

Are investors shorting Metlife?

Metlife saw a decline in short interest in June. As of June 29th, there was short interest totalling 12,020,672 shares, a decline of 28.9% from the June 15th total of 16,900,543 shares. Based on an average daily trading volume, of 7,086,353 shares, the days-to-cover ratio is presently 1.7 days. Currently, 1.4% of the company's shares are sold short. View Metlife's Current Options Chain.

Who are some of Metlife's key competitors?

Who are Metlife's key executives?

Metlife's management team includes the folowing people:
  • Mr. Steven Albert Kandarian, Chairman, Pres & CEO (Age 65)
  • Mr. Martin J. Lippert, Exec. VP and Head of Global Technology & Operations (Age 58)
  • Mr. Steven Jeffery Goulart, Exec. VP & Chief Investment Officer (Age 59)
  • Mr. Michel A. Khalaf, Pres of U.S. Bus. & EMEA (Age 54)
  • Mr. John Carroll Ramsey Hele, Sr. Adviser (Age 60)

Has Metlife been receiving favorable news coverage?

News stories about MET stock have been trending somewhat positive on Monday, Accern Sentiment Analysis reports. The research group identifies negative and positive press coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Metlife earned a news impact score of 0.15 on Accern's scale. They also assigned media stories about the financial services provider an impact score of 46.03 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company's share price in the near future.

Who are Metlife's major shareholders?

Metlife's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include BOARD OF DIRECTORS OF METLIFE INC (15.00%), Bank of Montreal Can (0.19%), NN Investment Partners Holdings N.V. (0.17%), Lodestar Investment Counsel LLC IL (0.04%), Gofen & Glossberg LLC IL (0.03%) and Fjarde AP Fonden Fourth Swedish National Pension Fund (0.02%). Company insiders that own Metlife stock include Christopher G Townsend, Frans Hijkoop, Gerald L Hassell, James M Kilts, Maria R Morris and Peter M Carlson. View Institutional Ownership Trends for Metlife.

Which major investors are selling Metlife stock?

MET stock was sold by a variety of institutional investors in the last quarter, including Bank of Montreal Can, Gofen & Glossberg LLC IL, Gateway Investment Advisers LLC, Cullinan Associates Inc., Fjarde AP Fonden Fourth Swedish National Pension Fund, CENTRAL TRUST Co, Cibc Bank USA and Ledyard National Bank. View Insider Buying and Selling for Metlife.

Which major investors are buying Metlife stock?

MET stock was purchased by a variety of institutional investors in the last quarter, including Farmers Trust Co., DAVENPORT & Co LLC, NN Investment Partners Holdings N.V., Addenda Capital Inc., State of Alaska Department of Revenue, IFM Investors Pty Ltd, CHURCHILL MANAGEMENT Corp and DnB Asset Management AS. Company insiders that have bought Metlife stock in the last two years include Gerald L Hassell and James M Kilts. View Insider Buying and Selling for Metlife.

How do I buy shares of Metlife?

Shares of MET can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Metlife's stock price today?

One share of MET stock can currently be purchased for approximately $44.22.

How big of a company is Metlife?

Metlife has a market capitalization of $44.93 billion and generates $62.09 billion in revenue each year. The financial services provider earns $4.01 billion in net income (profit) each year or $4.50 on an earnings per share basis. Metlife employs 49,000 workers across the globe.

How can I contact Metlife?

Metlife's mailing address is 200 Park Avenue, New York NY, 10166. The financial services provider can be reached via phone at 212-578-9500.

MarketBeat Community Rating for Metlife (NYSE MET)

Community Ranking:  3.1 out of 5 (star star star)
Outperform Votes:  701 (Vote Outperform)
Underperform Votes:  415 (Vote Underperform)
Total Votes:  1,116
MarketBeat's community ratings are surveys of what our community members think about Metlife and other stocks. Vote "Outperform" if you believe MET will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MET will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/16/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.